← FDA Drug Approvals (Drugs@FDA)

LUBIPROSTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-03-23

Drug application

FDA Application #

ANDA214131

Application type

Abbreviated New Drug Application (Generic)

Brand name

LUBIPROSTONE

Generic name

LUBIPROSTONE

Active ingredients

LUBIPROSTONE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2023-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown